Is a contrast‑enhanced CT required to evaluate surgical mesh placement?

CT With Contrast Is Not Required to Evaluate Mesh Placement

For evaluating surgical mesh placement, noncontrast CT is generally sufficient and often preferred, as the mesh visibility depends primarily on the material composition rather than contrast enhancement.

Understanding Mesh Radiopacity

The visibility of surgical mesh on imaging varies dramatically based on its material composition 1:

• Always visible meshes: Materials like Dualmesh are readily apparent on CT without contrast
• Readily visible: Composix-type meshes show good conspicuity
• Poorly visible: Prolene is barely discernible
• Not visible: Some meshes like Ultrapro cannot be seen on standard imaging

The key point is that mesh visibility is an inherent property of the material itself, not dependent on IV contrast administration 1.

Evidence for Noncontrast CT

Research specifically evaluating mesh placement demonstrates that noncontrast CT (MSCT) effectively visualizes radiopaque mesh implants and accurately assesses their size and location 2. In a study of 40 patients with titanium mesh implants, noncontrast MSCT successfully:

• Confirmed mesh location matched intraoperative placement
• Measured mesh dimensions accurately at 3 and 90 days post-surgery
• Detected no significant size changes over time

This demonstrates that when using appropriately radiopaque materials, noncontrast CT provides comprehensive evaluation of mesh placement outcomes 2.

When Contrast May Be Needed

IV contrast becomes necessary only when evaluating complications, not for assessing mesh placement itself. Based on ACR guidelines for postoperative complications 3:

• Abscess detection: IV contrast improves identification of fluid collections and abscesses
• Bowel wall integrity: Contrast is essential when evaluating for ischemia or anastomotic complications
• Inflammatory changes: Enhanced CT better demonstrates soft tissue inflammation

However, these indications relate to detecting surgical complications, not evaluating the mesh position or integrity.

Clinical Algorithm

For routine mesh placement evaluation:

1. Order noncontrast CT of the appropriate region
2. Verify the mesh material is radiopaque (check operative report)
3. If mesh is not visible and clinical concern persists, consider MRI

For suspected complications (infection, abscess, bowel injury):

1. Order CT with IV contrast
2. Consider adding rectal contrast if anastomotic leak suspected
3. Mesh visualization remains possible on contrast-enhanced studies

Important Caveats

• Material matters: Many polymeric meshes have poor radiographic contrast and may not be visible on any CT protocol 1
• Manufacturer information: Radiopaque properties are often insufficiently documented by manufacturers 1
• Metal meshes: Titanium and other metal-based meshes provide optimal visualization without contrast 2, 4

The bottom line: Contrast is not required for mesh placement evaluation—it's the mesh material composition that determines visibility, not the imaging protocol.